Biomedical device company Biotronik said it has finished enrolling patients and completed all planned MRI studies for phase B of its ProMRI pacemaker study.
In this phase of the trial, Biotronik is assessing the safety of the firm's Entovis pacemakers in patients who undergo full-body MRI scans, including cardiac and thoracic spinal studies, according to the vendor. Phase C, which is still underway, is investigating the safety of the vendor's Iforia and DX implantable cardioverter-defibrillator (ICD) devices for whole-body MRI exams, Biotronik said.
